Meitheal Pharmaceuticals Inc

2 FDA enforcement actions

2 Total Recalls

1 Class I

0 Class II

1 Class III

Firm Details

Product Types: drug
States: IL

All Recalls

Class III: Low Risk 09/03/2021 drug

Failed Impurities/Degradation Specifications
Class I: Dangerous 01/27/2021 drug

Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.